Michelle G. Burris's Insider Trades & SAST Disclosures
Michelle G. Burris's most recent trade in Adaptive Biotechnologies Corp was a trade of 36,291 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michelle G. Burris.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.19 per share. | 13 Mar 2025 | 36,291 | 15,394 (0%) | 0% | 7.2 | 260,932 | Common Stock |
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Sale of securities on an exchange or to another person at price $ 7.94 per share. | 04 Mar 2025 | 15,664 | 51,685 (0%) | 0% | 7.9 | 124,372 | Common Stock |
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 67,349 (0%) | 0% | 0 | Common Stock | |
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 51,955 (0%) | 0% | 0 | Common Stock | |
| Acer Therapeutics Inc | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Acer Therapeutics Inc | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Acer Therapeutics Inc | Michelle G. Burris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges